Risk of multiple myeloma is associated with polymorphisms within telomerase genes and telomere length

International Journal of Cancer

Volumn 136, Issue 5, 2015, Pages E351-E358

  Campa, Daniele ^a   Martino, Alessandro ^a   Varkonyi, Judit ^b   Lesueur, Fabienne ^c   Jamroziak, Krzysztof ^d   Landi, Stefano ^e   Jurczyszyn, Artur ^f   Marques, Herlander ^g,h   Andersen, Vibeke ^i,j   Jurado, Manuel ^k,l   Brenner, Hermann ^a   Petrini, Mario ^e   Vogel, Ulla ^m   García Sanz, Ramón ⁿ   Buda, Gabriele ^e   Gemignani, Federica ^e   Ríos, Rafael ^k,l   Vangsted, Annette Juul ^o   Dumontet, Charles ^p   Martínez López, Joaquín ^q   Moreno, María José ^r   Sterpień, Anna ^s   Wątek, Marzena ^t   Moreno, Victor ^u   Dieffenbach, Aida Karina ^a   Rossi, Anna Maria ^e   Butterbach, Katja ^a   Jacobsen, Svend E Hove ^v   Goldschmidt, Hartmut ^w   Sainz, Juan ^k,l   Hillengass, Jens ^w   Orciuolo, Enrico ^e   Dudziński, Marek ^x   Weinhold, Niels ^w   Reis, Rui Manuel ^g,h,y   Canzian, Federico ^a   more..

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^c PSL RESEARCH UNIVERSITY   (France)

^d MEDICAL UNIVERSITY OF LODZ   (Poland)

^e UNIVERSITY OF PISA   (Italy)

^f UNIVERSITY HOSPITAL IN KRAKOW   (Poland)

^g UNIVERSITY OF MINHO   (Portugal)

^h UNIVERSITY OF MINHO   (Portugal)

ⁱ Hospital of Southern Jutland   (Denmark)

^j UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^k UNIVERSITY OF GRANADA   (Spain)

^l HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^m NATIONAL RESEARCH CENTRE FOR THE WORKING ENVIRONMENT   (Denmark)

ⁿ HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^o UNIVERSITY OF COPENHAGEN   (Denmark)

^p UNIVERSITÉ LYON 1   (France)

^q HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^r HOSPITAL GENERAL UNIVERSITARIO REINA SOFÍA   (Spain)

^s POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

^t Holy Cross Cancer Center   (Poland)

^u UNIVERSITY OF BARCELONA   (Spain)

^v Sonderborg Hospital   (Denmark)

^w UNIVERSITY OF HEIDELBERG   (Germany)

^x Regional Hospital Rzeszow   (Poland)

^y BARRETOS CANCER HOSPITAL   (Brazil)

more..

Author keywords

Multiple myeloma; Polymorphisms; Susceptibility; Telomerase; Telomere length

Indexed keywords

ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; FEMALE; GENE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPING TECHNIQUE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIPLE MYELOMA; RETROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; TELOMERE HOMEOSTASIS; TERC GENE; TERT GENE; BIOLOGY; CASE CONTROL STUDY; CLINICAL TRIAL; COHORT ANALYSIS; FOLLOW UP; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GERMANY; LEUKOCYTE; MULTICENTER STUDY; PROGNOSIS; RISK FACTOR;

TELOMERASE; TERT PROTEIN, HUMAN;

AGED; CASE-CONTROL STUDIES; COHORT STUDIES; COMPUTATIONAL BIOLOGY; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GERMANY; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; MULTIPLE MYELOMA; POLYMORPHISM, GENETIC; PROGNOSIS; RISK FACTORS; TELOMERASE; TELOMERE HOMEOSTASIS;

EID: 84918779782     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29101     Document Type: Article

References (47)

1. Raab MS, Podar K, Breitkreutz I, et al. Multiple myeloma. Lancet 2009;374:324-39.
2. Martino A, Sainz J, Buda G, et al. Genetics and molecular epidemiology of multiple myeloma: the rationale for the IMMEnSE consortium (review). Int J Oncol 2012;40:625-38.
3. Altieri A, Chen B, Bermejo JL, et al. Familial risks and temporal incidence trends of multiple myeloma. Eur J Cancer 2006;42:1661-70.
4. Landgren O, Weiss BM. Patterns of monoclonal gammopathy of undetermined significance and multiple myeloma in various ethnic/racial groups: support for genetic factors in pathogenesis. Leukemia 2009;23:1691-7.
5. Broderick P, Chubb D, Johnson DC, et al. Common variation at 3p22.1 and 7p15.3 influences multiple myeloma risk. Nat Genet 2012;44:58-61.
6. Campa D, Martino A, Sainz J, et al. Comprehensive investigation of genetic variation in the 8q24 region and multiple myeloma risk in the IMMEnSE consortium. Br J Haematol 2012;157:331-8.
7. Chubb D, Weinhold N, Broderick P, et al. Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk. Nat Genet 2013;45:1221-5.
8. Martino A, Campa D, Buda G, et al. Polymorphisms in xenobiotic transporters ABCB1, ABCG2, ABCC2, ABCC1, ABCC3 and multiple myeloma risk: a case-control study in the context of the International Multiple Myeloma rESEarch (IMMEnSE) consortium. Leukemia 2012;26:1419-22.
9. Martino A, Campa D, Jamroziak K, et al. Impact of polymorphic variation at 7p15.3, 3p22.1 and 2p23.3 loci on risk of multiple myeloma. Br J Haematol 2012;158:805-9.
10. Vangsted A, Klausen TW, Vogel U. Genetic variations in multiple myeloma I: effect on risk of multiple myeloma. Eur J Haematol 2012;88:8-30.
11. Weinhold N, Johnson DC, Chubb D, et al. The CCND1 c.870G>A polymorphism is a risk factor for t (11;14) (q13;q32) multiple myeloma. Nat Genet 2013;45:522-5.
12. Bojesen SE, Pooley KA, Johnatty SE, et al. Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet 2013;45:371-84, 84e1-2.
13. Haiman CA, Chen GK, Vachon CM, et al. A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer. Nat Genet 2011;43:1210-4.
14. Kote-Jarai Z, Olama AA, Giles GG, et al. Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. Nat Genet 2011;43:785-91.
15. Kote-Jarai Z, Saunders EJ, Leongamornlert DA, et al. Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression. Hum Mol Genet 2013;22:2520-8.
16. McKay JD, Hung RJ, Gaborieau V, et al. Lung cancer susceptibility locus at 5p15.33. Nat Genet 2008;40:1404-6.
17. Petersen GM, Amundadottir L, Fuchs CS, et al. A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet 2010;42:224-8.
18. Rajaraman P, Melin BS, Wang Z, et al. Genomewide association study of glioma and meta-analysis. Hum Genet 2012;131:1877-88.
19. Rothman N, Garcia-Closas M, Chatterjee N, et al. A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat Genet 2010;42:978-84.
20. Turnbull C, Rapley EA, Seal S, et al. Variants near DMRT1, TERT and ATF7IP are associated with testicular germ cell cancer. Nat Genet 2010;42:604-7.
21. Wang Y, Broderick P, Webb E, et al. Common 5p15.33 and 6p21.33 variants influence lung cancer risk. Nat Genet 2008;40:1407-9.
22. Fingerlin TE, Murphy E, Zhang W, et al. Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis. Nat Genet 2013;45:613-20.
23. Gudmundsson J, Besenbacher S, Sulem P, et al. Genetic correction of PSA values using sequence variants associated with PSA levels. Sci Transl Med 2010;2:62ra92.
24. Mushiroda T, Wattanapokayakit S, Takahashi A, et al. A genome-wide association study identifies an association of a common variant in TERT with susceptibility to idiopathic pulmonary fibrosis. J Med Genet 2008;45:654-6.
25. Blackburn EH. Switching and signaling at the telomere. Cell 2001;106:661-73.
26. Armanios M. Telomeres and age-related disease: how telomere biology informs clinical paradigms. J Clin Investig 2013;123:996-1002.
27. Armanios M, Blackburn EH. The telomere syndromes. Nat Rev Genet 2012;13:693-704.
28. De Lange T. Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev 2005;19:2100-10.
29. De Lange T. How telomeres solve the endprotection problem. Science 2009;326:948-52.
30. Martinez P, Blasco MA. Telomeric and extratelomeric roles for telomerase and the telomerebinding proteins. Nat Rev Cancer 2011;11:161-76.
31. McEachern MJ, Krauskopf A, Blackburn EH. Telomeres and their control. Annu Rev Genet 2000;34:331-58.
32. Blasco MA. Telomeres and human disease: ageing, cancer and beyond. Nat Rev Genet 2005;6:611-22.
33. Wu X, Amos CI, Zhu Y, et al. Telomere dysfunction: a potential cancer predisposition factor. J Natl Cancer Inst 2003;95:1211-8.
34. Chung CC, Chanock SJ. Current status of genome-wide association studies in cancer. Hum Genet 2011;130:59-78.
35. Codd V, Nelson CP, Albrecht E, et al. Identification of seven loci affecting mean telomere length and their association with disease. Nat Genet 2013;45:422-7, 7e1-2.
36. Nan H, Qureshi AA, Prescott J, et al. Genetic variants in telomere-maintaining genes and skin cancer risk. Hum Genet 2011;129:247-53.
37. Roos G, Krober A, Grabowski P, et al. Short telomeres are associated with genetic complexity, high-risk genomic aberrations, and short survival in chronic lymphocytic leukemia. Blood 2008;111:2246-52.
38. Willeit P, Willeit J, Mayr A, et al. Telomere length and risk of incident cancer and cancer mortality. JAMA 2010;304:69-75.
39. Hosnijeh FS, Matullo G, Russo A, et al. Prediagnostic telomere length and risk of B-cell lymphoma-results from the EPIC cohort study. Int J Cancer J Int Cancer 2014; in press.
40. Kimura M, Gazitt Y, Cao X, et al. Synchrony of telomere length among hematopoietic cells. Exp Hematol 2010;38:854-9.
41. International Myeloma Working Group. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol 2003;121:749-57.
42. Jones AM, Beggs AD, Carvajal-Carmona L, et al. TERC polymorphisms are associated both with susceptibility to colorectal cancer and with longer telomeres. Gut 2012;61:248-54.
43. Cawthon RM. Telomere measurement by quantitative PCR. Nucleic Acids Res 2002;30:e47.
44. Gao X, Starmer J, Martin ER. A multiple testing correction method for genetic association studies using correlated single nucleotide polymorphisms. Genet Epidemiol 2008;32:361-9.
45. Boyle AP, Hong EL, Hariharan M, et al. Annotation of functional variation in personal genomes using RegulomeDB. Genome Res 2012;22:1790-7.
46. Ward LD, Kellis M. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res 2012;40:D930-4.
47. Grundberg E, Small KS, Hedman AK, et al. Mapping cis- and trans-regulatory effects across multiple tissues in twins. Nat Genet 2012;44:1084-9.